Medindia LOGIN REGISTER
Medindia
Advertisement

New Discovery may Help Create Less Toxic Anti-HIV Drugs

by VR Sreeraman on October 19, 2009 at 12:22 PM
 New Discovery may Help Create Less Toxic Anti-HIV Drugs

Scientists from The University of Texas at Austin have unravelled the atomic structure of a key human enzyme - a finding that would help create less toxic anti-HIV drugs.

"Many anti-HIV drugs are designed to stop the process of DNA replication," said Dr. Whitney Yin, assistant professor of chemistry and biochemistry.

Advertisement

"That turns out to be a great thing to do to help cure virus infections, because it stop the processes of viral replication.

"At the same time, however, when you target such a critical process in viruses, you may also target human enzymes that perform similar functions in normal cells, and this is what causes harmful drug side effects," Yin added.
Advertisement

During the study, Yin and Young-sam Lee unravelled the atomic structure of an enzyme, known as Pol ? (pol gamma), that is responsible for DNA replication in human mitochondria.

When mitochondria are working normally, they produce most of the energy that sustains human cells. When pol gamma comes into contact with certain anti-retroviral drugs, however, it can incorporate the drug into mitochondrial DNA, and thus interfere with the normal replication process.

This interferes with the ability of mitochondria to function. The consequences can range from simple nausea to bone marrow depletion to organ failure.

"Patients who are taking this class of anti-HIV drugs have suffered these drug toxicities for a long time. Dosages and combinations of drugs can be chosen so they don't kill you, but they still can't be used at their most effective concentrations against HIV," said Yin.

"However, in large part because combination therapies have become more successful and patients are living longer, toxicity has become more of an issue than before," Yin added.

The study is published this week in Cell.

Source: ANI
LIN
Font : A-A+

Advertisement

Advertisement
Advertisement

Latest Drug News

Can a Needle-Free Patch Transform Zika Protection?
Researchers create needle-free Zika vaccine patch, using HD-MAP tech, aiming to protect against fatal virus spread by mosquitoes.
Prolonging Market Exclusivity of Brand-name Insulin
Examining FDA and patent records, researchers found that insulin manufacturers prolong market exclusivity for brand-name products.
FDA Boosts Orphan Drug Designations for Myelofibrosis Treatments
The rise in FDA ODD awards indicates a collective endeavor to create new myelofibrosis medications devoid of mechanisms inducing anemia.
Anti-Rheumatic Drugs May Help Prevent Thyroid Disease
The most significant decrease in autoimmune thyroid disease risk was observed in rheumatoid arthritis patients receiving immunomodulatory drugs or 'biological DMARDs'.
Apotransferrin's Potential in Early Stroke Therapy Revealed
Human apotransferrin injected to mice models suffering from intracerebral hemorrhage was found to mitigate the serious effects of stroke.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
×

New Discovery may Help Create Less Toxic Anti-HIV Drugs Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests